Funding for this research was provided by:
Region Örebro län
Received: 14 April 2020
Accepted: 6 July 2020
First Online: 13 July 2020
Ethics approval and consent to participate
: The study was approved by the Regional Ethics Committee Review Board of Uppsala (reference number 2016/528). All participants gave informed consent for participation in the study.
: Not applicable.
: G.J. is a consultant for Novo Nordisk but does not consider this to be a relevant conflict of interest with regard to this work. R.T., J.A., U.J., and L-O.L. have no conflicts to declare.